scispace - formally typeset
A

Ajamete Kaykas

Researcher at Novartis

Publications -  44
Citations -  6768

Ajamete Kaykas is an academic researcher from Novartis. The author has contributed to research in topics: Wnt signaling pathway & Induced pluripotent stem cell. The author has an hindex of 25, co-authored 39 publications receiving 5788 citations. Previous affiliations of Ajamete Kaykas include Allen Institute for Brain Science & Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

WNT and β-catenin signalling: diseases and therapies

TL;DR: WNT signalling has been studied primarily in developing embryos, but WNTs also have important functions in adults, and aberrant signalling by WNT pathways is linked to a range of diseases, most notably cancer.
Journal ArticleDOI

Zebrafish Prickle, a Modulator of Noncanonical Wnt/Fz Signaling, Regulates Gastrulation Movements

TL;DR: The results support the idea that a vertebrate PCP pathway regulates gastrulation movements and suggest that there is overlap between the PCP and Wnt/calcium pathways.
Journal ArticleDOI

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

TL;DR: The results indicate that Cas9 toxicity creates an obstacle to the high-throughput use of CRISPR/Cas9 for genome engineering and screening in hPSCs, and as h PSCs can acquire P53 mutations14, cell replacement therapies using CRISpr/cas9-enginereed hPSCS should proceed with caution, and such engineered hPSPs should be monitored for P53 function.
Journal ArticleDOI

Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.

TL;DR: It is demonstrated that the antibiotic minocycline reduces microglia-mediated synapse uptake in vitro and its use is associated with a modest decrease in incident schizophrenia risk compared to other antibiotics in a cohort of young adults drawn from electronic health records.